Better Therapeutics, Inc.
BTTX
$0.0002
$0.000.00%
| Weiss Ratings | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 46.73 | |||
| Price History | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | 100.00% | |||
| 90-Day Total Return | 100.00% | |||
| Year to Date Total Return | 100.00% | |||
| 1-Year Total Return | -99.55% | |||
| 2-Year Total Return | -99.98% | |||
| 3-Year Total Return | -99.99% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -99.79% | |||
| 52-Week Low % Change | 19,900.00% | |||
| Price | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.10 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Aug 05, 2024 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.90K | |||
| Enterprise Value | 7.72M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -1.16 | |||
| Earnings Per Share Growth | -40.97% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -0.28 | |||
| Enterprise Value/EBIT | -0.26 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 38.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 415 887 2311 | |||
| Address | 548 Market Street San Francisco, CA 94104 | |||
| Website | www.bettertx.com | |||
| Country | United States | |||
| Year Founded | 2015 | |||
| Profitability | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -95.05% | |||
| Return on Equity | -- | |||
| Income Statement | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -27.21M | |||
| EBIT (TTM) | -29.61M | |||
| Net Income (TTM) | -31.57M | |||
| Net Income Avl. to Common (TTM) | -31.57M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 48.60% | |||
| EPS Diluted (TTM) | -1.16 | |||
| EPS Diluted Growth (Q YOY) | 68.36% | |||
| Balance Sheet | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 6.60M | |||
| Cash Per Share (Q) | $0.17 | |||
| Total Current Assets (Q) | 7.35M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -9.94M | |||
| Current Ratio (Q) | 0.568 | |||
| Book Value Per Share (Q) | -$0.24 | |||
| Total Assets (Q) | 10.72M | |||
| Total Current Liabilities (Q) | 12.94M | |||
| Total Debt (Q) | 14.31M | |||
| Total Liabilities (Q) | 20.66M | |||
| Total Common Equity (Q) | -9.94M | |||
| Cash Flow | BTTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.32M | |||
| Cash from Financing (TTM) | 11.69M | |||
| Net Change in Cash (TTM) | -15.71M | |||
| Levered Free Cash Flow (TTM) | -16.45M | |||
| Cash from Operations (TTM) | -26.08M | |||
